The DOI matches its Crossref record; 106 of the 106 references it cites were found in a registry or an index.
SARS-CoV-2/COVID-19: Viral Genomics, Epidemiology, Vaccines, and Therapeutic Interventions
Open accessAbstract
The COVID-19 pandemic is due to infection caused by the novel SARS-CoV-2 virus that impacts the lower respiratory tract. The spectrum of symptoms ranges from asymptomatic infections to mild respiratory symptoms to the lethal form of COVID-19 which is associated with severe pneumonia, acute respiratory distress, and fatality. To address this global crisis, up-to-date information on viral genomics and transcriptomics is crucial for understanding the origins and global dispersion of the virus, providing insights into viral pathogenicity, transmission, and epidemiology, and enabling strategies for therapeutic interventions, drug discovery, and vaccine development. Therefore, this review provides a comprehensive overview of COVID-19 epidemiology, genomic etiology, findings from recent transcriptomic map analysis, viral-human protein interactions, molecular diagnostics, and the current status of vaccine and novel therapeutic intervention development. Moreover, we provide an extensive list of resources that will help the scientific community access numerous types of databases related to SARS-CoV-2 OMICs and approaches to therapeutics related to COVID-19 treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Gautret, P., Lagier, J.-C., Parola, P., Hoang, V. T., Meddeb, L., Mailhe, M., Doudier, B., Courjon, J., Giordanengo, V., Vieira, V. E., et al. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.105949 · Cited by 5,288
RetractedExperimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study
Cai, Q., Yang, M., Liu, D., Chen, J., Shu, D., Xia, J., Liao, X., Gu, Y., Cai, Q., Yang, Y., et al. (2020) · Engineering · doi:10.1016/j.eng.2020.03.007 · Cited by 1,357
RetractedClinical characteristics of coronavirus disease 2019 in China
Guan, W.-J., Ni, Z.-Y., Hu, Y., Liang, W.-H., Ou, C.-Q., He, J.-X., Liu, L., Shan, H., Lei, C.-L., Hui, D. S. C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2002032 · Cited by 30,246
A novel coronavirus from patients with pneumonia in China, 2019
Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., Zhao, X., Huang, B., Shi, W., Lu, R., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001017 · Cited by 28,244
Hoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., Schiergens, T. S., Herrler, G., Wu, N.-H., Nitsche, A., et al. (2020) · Cell · doi:10.1016/j.cell.2020.02.052 · Cited by 20,286
Yang, X., Yu, Y., Xu, J., Shu, H., Xia, J., Liu, H., Wu, Y., Zhang, L., Yu, Z., Fang, M., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30079-5 · Cited by 10,066
Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1
van Doremalen, N., Bushmaker, T., Morris, D. H., Holbrook, M. G., Gamble, A., Williamson, B. N., Tamin, A., Harcourt, J. L., Thornburg, N. J., Gerber, S. I., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2004973 · Cited by 9,951 · cited 3×
“Overall, the findings indicate that continued aerosol and fomite transmission (see Box 1) of SARS-CoV-2 is highly plausible as the virus remains infectious in droplets for numerous hours and on surfaces for up to three days [17,20].”
BackgroundWang, M., Cao, R., Zhang, L., Yang, X., Liu, J., Xu, M., Shi, Z., Hu, Z., Zhong, W., & Xiao, G. (2020) · Cell Research · doi:10.1038/s41422-020-0282-0 · Cited by 6,958
Hamming, I., Timens, W., Bulthuis, M., Lely, A., Navis, G., & van Goor, H. (2004) · The Journal of Pathology · doi:10.1002/path.1570 · Cited by 5,676 · cited 1×
“ACE2 is primarily found in the lower respiratory tract of humans on epithelial cells lining the lung alveoli and bronchioles as well as the endothelial cells and myocytes of pulmonary blood vessels, partly explaining the severe respiratory syndrome associated with these viruses [48].”
BackgroundA Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19
Cao, B., Wang, Y., Wen, D., Liu, W., Wang, J., Fan, G., Ruan, L., Song, B., Cai, Y., Wei, M., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001282 · Cited by 5,187
The proximal origin of SARS-CoV-2
Andersen, K. G., Rambaut, A., Lipkin, W. I., Holmes, E. C., & Garry, R. F. (2020) · Nature Medicine · doi:10.1038/s41591-020-0820-9 · Cited by 5,081
SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients
Zou, L., Ruan, F., Huang, M., Liang, L., Huang, H., Hong, Z., Yu, J., Kang, M., Song, Y., Xia, J., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2001737 · Cited by 4,810
Presumed Asymptomatic Carrier Transmission of COVID-19
Bai, Y., Yao, L., Wei, T., Tian, F., Jin, D.-Y., Chen, L., & Wang, M. (2020) · JAMA · doi:10.1001/jama.2020.2565 · Cited by 4,498
A SARS-CoV-2 protein interaction map reveals targets for drug repurposing
Gordon, D. E., Jang, G. M., Bouhaddou, M., Xu, J., Obernier, K., White, K. M., O’Meara, M. J., Rezelj, V. V., Guo, J. Z., Swaney, D. L., et al. (2020) · Nature · doi:10.1038/s41586-020-2286-9 · Cited by 4,405
Li, R., Pei, S., Chen, B., Song, Y., Zhang, T., Yang, W., & Shaman, J. (2020) · Science · doi:10.1126/science.abb3221 · Cited by 3,633
Wang, Y., Zhang, D., Du, G., Du, R., Zhao, J., Jin, Y., Fu, S., Gao, L., Cheng, Z., Lu, Q., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31022-9 · Cited by 3,440
Nextstrain: real-time tracking of pathogen evolution
Hadfield, J., Megill, C., Bell, S. M., Huddleston, J., Potter, B., Callender, C., Sagulenko, P., Bedford, T., & Neher, R. A. (2018) · Bioinformatics · doi:10.1093/bioinformatics/bty407 · Cited by 3,154
Structure, Function, and Evolution of Coronavirus Spike Proteins
Li, F. (2016) · Annual Review of Virology · doi:10.1146/annurev-virology-110615-042301 · Cited by 2,740
Compassionate Use of Remdesivir for Patients with Severe Covid-19
Grein, J., Ohmagari, N., Shin, D., Diaz, G., Asperges, E., Castagna, A., Feldt, T., Green, G., Green, M. L., Lescure, F.-X., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2007016 · Cited by 2,737
Zhang, H., Penninger, J. M., Li, Y., Zhong, N., & Slutsky, A. S. (2020) · Intensive Care Medicine · doi:10.1007/s00134-020-05985-9 · Cited by 2,684
Gao, J., Tian, Z., & Yang, X. (2020) · BioScience Trends · doi:10.5582/bst.2020.01047 · Cited by 2,590
Bats Are Natural Reservoirs of SARS-Like Coronaviruses
Li, W., Shi, Z., Yu, M., Ren, W., Smith, C., Epstein, J. H., Wang, H., Crameri, G., Hu, Z., Zhang, H., et al. (2005) · Science · doi:10.1126/science.1118391 · Cited by 2,560
HCA Lung Biological Network, Sungnak, W., Huang, N., Bécavin, C., Berg, M., Queen, R., Litvinukova, M., Talavera-López, C., Maatz, H., Reichart, D., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0868-6 · Cited by 2,501
CDC COVID-19 Response Team, CDC COVID-19 Response Team, Bialek, S., Boundy, E., Bowen, V., Chow, N., Cohn, A., Dowling, N., Ellington, S., Gierke, R., et al. (2020) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6912e2 · Cited by 2,277
Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma
Shen, C., Wang, Z., Zhao, F., Yang, Y., Li, J., Yuan, J., Wang, F., Li, D., Yang, M., Xing, L., et al. (2020) · JAMA · doi:10.1001/jama.2020.4783 · Cited by 2,277
Ong, S. W. X., Tan, Y. K., Chia, P. Y., Lee, T. H., Ng, O. T., Wong, M. S. Y., & Marimuthu, K. (2020) · JAMA · doi:10.1001/jama.2020.3227 · Cited by 2,140
The Architecture of SARS-CoV-2 Transcriptome
Kim, D., Lee, J.-Y., Yang, J.-S., Kim, J. W., Kim, V. N., & Chang, H. (2020) · Cell · doi:10.1016/j.cell.2020.04.011 · Cited by 2,123 · cited 6×
“By combining both sequencing and RNA modification data, scientists in South Korea have identified 41 potential RNA modification sites that could be important for virus replication and its associated pathogenesis [27].”
BackgroundMethodInfluentialMonteil, V., Kwon, H., Prado, P., Hagelkrüys, A., Wimmer, R. A., Stahl, M., Leopoldi, A., Garreta, E., Hurtado del Pozo, C., Prosper, F., et al. (2020) · Cell · doi:10.1016/j.cell.2020.04.004 · Cited by 2,122 · cited 1×
“Consistent with this hypothesis, a recent in vitro study has shown that clinical-grade human recombinant soluble ACE2 (hrsACE2), but not mouse soluble ACE2, could curtail replication of SARS-CoV-2, resulting in reduced viral loads drastically in Vero cells in a dose dependent manner [68].”
ResultEffectiveness of convalescent plasma therapy in severe COVID-19 patients
Duan, K., Liu, B., Li, C., Zhang, H., Yu, T., Qu, J., Zhou, M., Chen, L., Meng, S., Hu, Y., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2004168117 · Cited by 1,960
The COVID-19 vaccine development landscape
Thanh Le, T., Andreadakis, Z., Kumar, A., Gómez Román, R., Tollefsen, S., Saville, M., & Mayhew, S. (2020) · Nature Reviews Drug Discovery · doi:10.1038/d41573-020-00073-5 · Cited by 1,954
Stability of SARS-CoV-2 in different environmental conditions
Chin, A. W. H., Chu, J. T. S., Perera, M. R. A., Hui, K. P. Y., Yen, H.-L., Chan, M. C. W., Peiris, M., & Poon, L. L. M. (2020) · doi:10.1101/2020.03.15.20036673 · Cited by 1,948 · cited 1×
“Overall, the findings indicate that continued aerosol and fomite transmission (see Box 1) of SARS-CoV-2 is highly plausible as the virus remains infectious in droplets for numerous hours and on surfaces for up to three days [17,20].”
Stability of SARS-CoV-2 in different environmental conditions
Chin, A. W. H., Chu, J. T. S., Perera, M. R. A., Hui, K. P. Y., Yen, H.-L., Chan, M. C. W., Peiris, M., & Poon, L. L. M. (2020) · The Lancet Microbe · doi:10.1016/s2666-5247(20)30003-3 · Cited by 1,946
Li, Z., Yi, Y., Luo, X., Xiong, N., Liu, Y., Li, S., Sun, R., Wang, Y., Hu, B., Chen, W., et al. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25727 · Cited by 1,771
Zhang, C., Wu, Z., Li, J.-W., Zhao, H., & Wang, G.-Q. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.105954 · Cited by 1,758
Sheahan, T. P., Sims, A. C., Leist, S. R., Schäfer, A., Won, J., Brown, A. J., Montgomery, S. A., Hogg, A., Babusis, D., Clarke, M. O., et al. (2020) · Nature Communications · doi:10.1038/s41467-019-13940-6 · Cited by 1,738
Airborne transmission of SARS-CoV-2: The world should face the reality
Morawska, L., & Cao, J. (2020) · Environment International · doi:10.1016/j.envint.2020.105730 · Cited by 1,728
Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings
Chu, C. M. (2004) · Thorax · doi:10.1136/thorax.2003.012658 · Cited by 1,645
High Contagiousness and Rapid Spread of Severe Acute Respiratory Syndrome Coronavirus 2
Sanche, S., Lin, Y. T., Xu, C., Romero-Severson, E., Hengartner, N., & Ke, R. (2020) · Emerging Infectious Diseases · doi:10.3201/eid2607.200282 · Cited by 1,619
On the origin and continuing evolution of SARS-CoV-2
Tang, X., Wu, C., Li, X., Song, Y., Yao, X., Wu, X., Duan, Y., Zhang, H., Wang, Y., Qian, Z., et al. (2020) · National Science Review · doi:10.1093/nsr/nwaa036 · Cited by 1,616
Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2
Zhou, Y., Hou, Y., Shen, J., Huang, Y., Martin, W., & Cheng, F. (2020) · Cell Discovery · doi:10.1038/s41421-020-0153-3 · Cited by 1,597
Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses
Sheahan, T. P., Sims, A. C., Graham, R. L., Menachery, V. D., Gralinski, L. E., Case, J. B., Leist, S. R., Pyrc, K., Feng, J. Y., Trantcheva, I., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aal3653 · Cited by 1,571
Mechanisms of Coronavirus Cell Entry Mediated by the Viral Spike Protein
Belouzard, S., Millet, J. K., Licitra, B. N., & Whittaker, G. R. (2012) · Viruses · doi:10.3390/v4061011 · Cited by 1,368
Seasonality of Respiratory Viral Infections
Moriyama, M., Hugentobler, W. J., & Iwasaki, A. (2020) · Annual Review of Virology · doi:10.1146/annurev-virology-012420-022445 · Cited by 1,266
Sungnak, W., Huang, N., Bécavin, C., & Berg, M. (2020) · PubMed Central · Cited by 1,196
SARS-CoV-2 Vaccines: Status Report
Amanat, F., & Krammer, F. (2020) · Immunity · doi:10.1016/j.immuni.2020.03.007 · Cited by 1,120
Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase
FURUTA, Y., KOMENO, T., & NAKAMURA, T. (2017) · Proceedings of the Japan Academy, Series B · doi:10.2183/pjab.93.027 · Cited by 1,070
Phylogenetic network analysis of SARS-CoV-2 genomes
Forster, P., Forster, L., Renfrew, C., & Forster, M. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2004999117 · Cited by 1,020
Emerging SARS-CoV-2 mutation hot spots include a novel RNA-dependent-RNA polymerase variant
Pachetti, M., Marini, B., Benedetti, F., Giudici, F., Mauro, E., Storici, P., Masciovecchio, C., Angeletti, S., Ciccozzi, M., Gallo, R. C., et al. (2020) · Journal of Translational Medicine · doi:10.1186/s12967-020-02344-6 · Cited by 996
Gordon, C. J., Tchesnokov, E. P., Woolner, E., Perry, J. K., Feng, J. Y., Porter, D. P., & Götte, M. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra120.013679 · Cited by 985
Use of convalescent plasma therapy in SARS patients in Hong Kong
Cheng, Y., Wong, R., Soo, Y. O. Y., Wong, W. S., Lee, C. K., Ng, M. H. L., Chan, P., Wong, K. C., Leung, C. B., & Cheng, G. (2005) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-004-1271-9 · Cited by 958
de Wit, E., Feldmann, F., Cronin, J., Jordan, R., Okumura, A., Thomas, T., Scott, D., Cihlar, T., & Feldmann, H. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1922083117 · Cited by 887
Eubank, S., Eckstrand, I., Lewis, B., Venkatramanan, S., Marathe, M., & Barrett, C. L. (2020) · Bulletin of Mathematical Biology · doi:10.1007/s11538-020-00726-x · Cited by 881
Cao, Y., Li, L., Feng, Z., Wan, S., Huang, P., Sun, X., Wen, F., Huang, X., Ning, G., & Wang, W. (2020) · Cell Discovery · doi:10.1038/s41421-020-0147-1 · Cited by 865
Gordon, C. J., Tchesnokov, E. P., Feng, J. Y., Porter, D. P., & Götte, M. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ac120.013056 · Cited by 850
Genomic characterization of a novel SARS-CoV-2
Khailany, R. A., Safdar, M., & Ozaslan, M. (2020) · Gene Reports · doi:10.1016/j.genrep.2020.100682 · Cited by 847
Why are RNA virus mutation rates so damn high?
Duffy, S. (2018) · PLOS Biology · doi:10.1371/journal.pbio.3000003 · Cited by 752
Molina, J. M., Delaugerre, C., Le Goff, J., Mela-Lima, B., Ponscarme, D., Goldwirt, L., & de Castro, N. (2020) · Médecine et Maladies Infectieuses · doi:10.1016/j.medmal.2020.03.006 · Cited by 749
de Wilde, A. H., Jochmans, D., Posthuma, C. C., Zevenhoven-Dobbe, J. C., van Nieuwkoop, S., Bestebroer, T. M., van den Hoogen, B. G., Neyts, J., & Snijder, E. J. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03011-14 · Cited by 736
Effects of Air Temperature and Relative Humidity on Coronavirus Survival on Surfaces
Casanova, L. M., Jeon, S., Rutala, W. A., Weber, D. J., & Sobsey, M. D. (2010) · Applied and Environmental Microbiology · doi:10.1128/aem.02291-09 · Cited by 735
A Review of SARS-CoV-2 and the Ongoing Clinical Trials
Tu, Y.-F., Chien, C.-S., Yarmishyn, A. A., Lin, Y.-Y., Luo, Y.-H., Lin, Y.-T., Lai, W.-Y., Yang, D.-M., Chou, S.-J., Yang, Y.-P., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21072657 · Cited by 686
Hung, I. F., To, K. K., Lee, C.-K., Lee, K.-L., Chan, K., Yan, W.-W., Liu, R., Watt, C.-L., Chan, W.-M., Lai, K.-Y., et al. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/ciq106 · Cited by 678
Setti, L., Passarini, F., De Gennaro, G., Barbieri, P., Perrone, M. G., Borelli, M., Palmisani, J., Di Gilio, A., Piscitelli, P., & Miani, A. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17082932 · Cited by 670
Stadlbauer, D., Amanat, F., Chromikova, V., Jiang, K., Strohmeier, S., Arunkumar, G. A., Tan, J., Bhavsar, D., Capuano, C., Kirkpatrick, E., et al. (2020) · Current Protocols in Microbiology · doi:10.1002/cpmc.100 · Cited by 649
Lim, J., Jeon, S., Shin, H.-Y., Kim, M. J., Seong, Y. M., Lee, W. J., Choe, K.-W., Kang, Y. M., Lee, B., & Park, S.-J. (2020) · Journal of Korean Medical Science · doi:10.3346/jkms.2020.35.e79 · Cited by 636
History and Recent Advances in Coronavirus Discovery
Kahn, J. S., & McIntosh, K. (2005) · Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000188166.17324.60 · Cited by 619
Chan, J. F.-W., Yao, Y., Yeung, M.-L., Deng, W., Bao, L., Jia, L., Li, F., Xiao, C., Gao, H., Yu, P., et al. (2015) · Journal of Infectious Diseases · doi:10.1093/infdis/jiv392 · Cited by 608
Bat-to-human: spike features determining ‘host jump’ of coronaviruses SARS-CoV, MERS-CoV, and beyond
Lu, G., Wang, Q., & Gao, G. F. (2015) · Trends in Microbiology · doi:10.1016/j.tim.2015.06.003 · Cited by 607
Ashour, H. M., Elkhatib, W. F., Rahman, M. M., & Elshabrawy, H. A. (2020) · Pathogens · doi:10.3390/pathogens9030186 · Cited by 607
GS-5734 and its parent nucleoside analog inhibit Filo-, Pneumo-, and Paramyxoviruses
Lo, M. K., Jordan, R., Arvey, A., Sudhamsu, J., Shrivastava-Ranjan, P., Hotard, A. L., Flint, M., McMullan, L. K., Siegel, D., Clarke, M. O., et al. (2017) · Scientific Reports · doi:10.1038/srep43395 · Cited by 513
The race for coronavirus vaccines: a graphical guide
Callaway, E. (2020) · Nature · doi:10.1038/d41586-020-01221-y · Cited by 492
Burke, R. M., Midgley, C. M., Dratch, A., Fenstersheib, M., Haupt, T., Holshue, M., Ghinai, I., Jarashow, M. C., Lo, J., McPherson, T. D., et al. (2020) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6909e1 · Cited by 475
Wang, Y., Kang, H., Liu, X., & Tong, Z. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25721 · Cited by 454
Chan, K., Lai, S. T., Chu, C., Tsui, E. L. H., Tam, C. Y., Wong, M. M.-L., Tse, M. W., Que, T. L., Peiris, M. J. S., Sung, J. J. �., et al. (2003) · PubMed · Cited by 423
Impact of temperature on the dynamics of the COVID-19 outbreak in China
Shi, P., Dong, Y., Yan, H., Zhao, C., Li, X., Liu, W., He, M., Tang, S., & Xi, S. (2020) · Science of The Total Environment · doi:10.1016/j.scitotenv.2020.138890 · Cited by 407
Genomic variance of the 2019‐nCoV coronavirus
Ceraolo, C., & Giorgi, F. M. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25700 · Cited by 397
Coronavirus Cell Entry Occurs through the Endo-/Lysosomal Pathway in a Proteolysis-Dependent Manner
Burkard, C., Verheije, M. H., Wicht, O., van Kasteren, S. I., van Kuppeveld, F. J., Haagmans, B. L., Pelkmans, L., Rottier, P. J. M., Bosch, B. J., & de Haan, C. A. M. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004502 · Cited by 388
Liu, P., Chen, W., & Chen, J.-P. (2019) · Viruses · doi:10.3390/v11110979 · Cited by 388
Luan, J., Lu, Y., Jin, X., & Zhang, L. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.03.047 · Cited by 378
Ko, J.-H., Seok, H., Cho, S. Y., Ha, Y. E., Baek, J. Y., Kim, S. H., Kim, Y.-J., Park, J. K., Chung, C. R., Kang, E.-S., et al. (2018) · Antiviral Therapy · doi:10.3851/imp3243 · Cited by 323
Association between climate variables and global transmission oF SARS-CoV-2
Sobral, M. F. F., Duarte, G. B., da Penha Sobral, A. I. G., Marinho, M. L. M., & de Souza Melo, A. (2020) · Science of The Total Environment · doi:10.1016/j.scitotenv.2020.138997 · Cited by 278
The outbreak of SARS-CoV-2 pneumonia calls for viral vaccines
Shang, W., Yang, Y., Rao, Y., & Rao, X. (2020) · npj Vaccines · doi:10.1038/s41541-020-0170-0 · Cited by 275
Zhao, M. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.105982 · Cited by 274
Rational Use of Tocilizumab in the Treatment of Novel Coronavirus Pneumonia
Zhang, S., Li, L., Shen, A., Chen, Y., & Qi, Z. (2020) · Clinical Drug Investigation · doi:10.1007/s40261-020-00917-3 · Cited by 212
Yan, D., Liu, X.-Y., Zhu, Y.-N., Huang, L., Dan, B.-T., Zhang, G.-J., & Gao, Y.-H. (2020) · European Respiratory Journal · doi:10.1183/13993003.00799-2020 · Cited by 197
Li, C., Zhu, X., Ji, X., Quanquin, N., Deng, Y.-Q., Tian, M., Aliyari, R., Zuo, X., Yuan, L., Afridi, S. K., et al. (2017) · EBioMedicine · doi:10.1016/j.ebiom.2017.09.034 · Cited by 169
SARS-CoV and emergent coronaviruses: viral determinants of interspecies transmission
Bolles, M., Donaldson, E., & Baric, R. (2011) · Current Opinion in Virology · doi:10.1016/j.coviro.2011.10.012 · Cited by 166
RNA Recombination Enhances Adaptability and Is Required for Virus Spread and Virulence
Xiao, Y., Rouzine, I. M., Bianco, S., Acevedo, A., Goldstein, E. F., Farkov, M., Brodsky, L., & Andino, R. (2016) · Cell Host & Microbe · doi:10.1016/j.chom.2016.03.009 · Cited by 157 · cited 1×
“This rapid evolution of SARS-CoV-2 is not surprising as coronaviruses habour error-prone RNA-dependent RNA polymerases which make the occurrence of mutations and recombination events rather frequent [34-37].”
BackgroundStefanelli, P., Faggioni, G., Presti, A. L., et al. (2020) · Eurosurveillance · doi:10.2807/1560-7917.es.2020.25.13.2000305 · Cited by 148
Hodgson, J. (2020) · Nature Biotechnology · doi:10.1038/d41587-020-00005-z · Cited by 145
Kaushik, N., Subramani, C., Anang, S., Muthumohan, R., Shalimar, S., Nayak, B., Ranjith-Kumar, C. T., & Surjit, M. (2017) · Journal of Virology · doi:10.1128/jvi.00754-17 · Cited by 143
Early Epidemiological and Clinical Characteristics of 28 Cases of Coronavirus Disease in South Korea
(2020) · Osong Public Health and Research Perspectives · doi:10.24171/j.phrp.2020.11.1.03 · Cited by 133
Dowall, S., Bosworth, A., Watson, R. J., Bewley, K. R., Taylor, I., Rayner, E. L., Hunter, L. E., Pearson, G., Easterbrook, L., Pitman, J. K., et al. (2015) · Journal of General Virology · doi:10.1099/jgv.0.000309 · Cited by 127
The Role of Augmented Intelligence (AI) in Detecting and Preventing the Spread of Novel Coronavirus
Long, J. B., & Ehrenfeld, J. M. (2020) · Journal of Medical Systems · doi:10.1007/s10916-020-1536-6 · Cited by 112
Is BCG vaccination affecting the spread and severity of COVID‐19?
Özdemir, C., Küçüksezer, U. C., & Tamay, Z. (2020) · Allergy · doi:10.1111/all.14344 · Cited by 112
Shittu, M. O., & Afolami, O. I. (2020) · PubMed · Cited by 89
Akpovwa, H. (2016) · Cell Biochemistry and Function · doi:10.1002/cbf.3182 · Cited by 88
Patil, S. P., Lis, L., Schumacher, R. J., et al. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01329 · Cited by 79
An emerging role for p21-activated kinases (Paks) in viral infections
den Broeke, C. V., Radu, M., Chernoff, J., & Favoreel, H. W. (2010) · Trends in Cell Biology · doi:10.1016/j.tcb.2009.12.005 · Cited by 65
Oh, S., Shin, J. H., Jang, E. J., Won, H. Y., Kim, H. K., Jeong, M. G., Kim, K. S., & Hwang, E. S. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.04.105 · Cited by 59
Development of novel entry inhibitors targeting emerging viruses
Zhou, Y., & Simmons, G. (2012) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.12.104 · Cited by 58
Nguyen, B. C. Q., Yoshimura, K., Kumazawa, S., Tawata, S., & Maruta, H. (2017) · Drug Discoveries & Therapeutics · doi:10.5582/ddt.2017.01011 · Cited by 55
Liang, S. H., Southon, A. G., Fraser, B. H., Krause‐Heuer, A. M., Zhang, B., Shoup, T. M., Lewis, R., Volitakis, I., Han, Y., Greguric, I. D., et al. (2015) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.5b00281 · Cited by 52
Smith, E. C. (2017) · PLoS Pathogens · doi:10.1371/journal.ppat.1006254 · Cited by 50
Coronaviruses Induce Entry-Independent, Continuous Macropinocytosis
Freeman, M. C., Peek, C. T., Becker, M. M., Smith, E. C., & Denison, M. R. (2014) · mBio · doi:10.1128/mbio.01340-14 · Cited by 49
RNA Virus Fidelity Mutants: A Useful Tool for Evolutionary Biology or a Complex Challenge?
Kautz, T. F., & Forrester, N. L. (2018) · Viruses · doi:10.3390/v10110600 · Cited by 44
Role of the p21-activated kinases (PAKs) in influenza A virus replication
Pascua, P. N. Q., Lee, J., Song, M., Park, S.-J., Baek, Y. H., Ann, B.-H., Shin, E., Kim, E., & Choi, Y. K. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.09.119 · Cited by 21
Cited by
Seasonality of Respiratory Viral Infections
Moriyama, M., Hugentobler, W. J., & Iwasaki, A. (2020) · Annual Review of Virology · doi:10.1146/annurev-virology-012420-022445 · Cited by 1,266
Ashour, H. M., Elkhatib, W. F., Rahman, M. M., & Elshabrawy, H. A. (2020) · Pathogens · doi:10.3390/pathogens9030186 · Cited by 607
The COVID-19 pandemic: a global health crisis
Pollard, C. A., Morran, M. P., & Nestor-Kalinoski, A. L. (2020) · Physiological Genomics · doi:10.1152/physiolgenomics.00089.2020 · Cited by 514
SARS-CoV-2 variant evasion of monoclonal antibodies based on in vitro studies
Cox, M., Peacock, T. P., Harvey, W. T., Hughes, J., Wright, D. W., COVID-19 Genomics UK (COG-UK) Consortium, Willett, B. J., Thomson, E., Gupta, R. K., Peacock, S. J., et al. (2023) · Nature Reviews Microbiology · doi:10.1038/s41579-022-00809-7 · Cited by 344
COVID-19 outbreak: history, mechanism, transmission, structural studies and therapeutics
Yesudhas, D., Srivastava, A., & Gromiha, M. M. (2021) · Infection · doi:10.1007/s15010-020-01516-2 · Cited by 270
Metadata
- Authors
- Uddin, M., Mustafa, F., Rizvi, T. A., Loney, T., Al Suwaidi, H., Al-Marzouqi, A. H. H., Kamal Eldin, A., Alsabeeha, N., Adrian, T. E., Stefanini, C., Nowotny, N., Alsheikh-Ali, A., & Senok, A. C.
- Venue
- Viruses
- Publisher
- MDPI AG
- Published
- 2020-05-10
- Volume
- 12
- Issue
- 5
- Pages
- 526
- ISSN
- 1999-4915 (ISSN-L)
- OpenAlex
- W3015181278
- Cited by
- 319
- References
- 106
- FWCI
- 8.39
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.